Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is being conducted to determine the clinical safety and efficacy of Pro-2-Cool mediated head and neck cooling when applied after concussion and improved symptomatology among adolescent athletes as quantified by post-concussion symptom severity (PCSS) score.
This is a multi-center, prospective, randomized, double-blinded, dual-arm comparative study enrolling up to a total of 66 patients (approximately 33 patients in the treatment arm and 33 patients in the control arm) following sports-related, concussion.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pro2Cool intervention with standard of care | Experimental | The treatment arm will receive standard of care for concussion along with 30 minutes of headneck cooling in the clinic while being monitored for side effects. The Pro2Cool® will be used to provide head and neck cooling. |
|
| Sham Pro2Cool with standard of care | Sham Comparator | The control arm will receive standard of care like the treatment group, along with 30 minutes of sham Pro2Cool® placement in the clinic while being monitored for side effects. The Pro2Cool® device will not be used to provide neck cooling; a sham cooling garment device will be placed with impaired cooling function (only to the head), with sham treatment temperature being set to 19°C (instead of the therapeutic 6°C specification). |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pro2Cool Device | Device | The Pro2Cool Device is a non-invasive hypothermic therapy ("cold therapy") device that provides localized cooling of the head and neck. Water and isopropyl alcohol cooled to 6°C by the chiller assembly circulate through the cooling garment to create conductive heat transfer from the scalp and carotid arteries, thus achieving cooling of the brain. |
| Measure | Description | Time Frame |
|---|---|---|
| Change quantified by post-concussion symptom severity (PCSS) assessment score | Post-injury to 72-hour follow-up |
| Measure | Description | Time Frame |
|---|---|---|
| Number of adverse events associated with the head-and-neck cooling treatment | Treatment to 72-hour follow-up |
Not provided
Inclusion Criteria:
Males and females, 13-21 years of age
Confirmed concussion diagnosis consistent with American Congress Rehabilitation Medicine guidelines 21, without any of the following:
Glasgow Coma Scale (GCS) ≥ 13 at the time of initial injury for study enrollment.
Post-Concussion Symptom Scale Score minimum of 15
Initial provider visit is within 7 days of injury
In generally good health as confirmed by medical history and determined by site investigator or designated trained healthcare professional under the supervision of the principal investigator.
Has informed consent obtained per protocol and as required per Institutional Review Board
Exclusion Criteria:
Age < 13 years or > 21 years
Inability to understand the study requirements or provide informed consent
Cleared to return to play during initial visit
Prior participation in a Pro2Cool Clinical Study
Serious traumatic brain injury as evidenced by worsening symptoms:
Physical (e.g., head or neck injury that requires medical treatment) or mental disability hindering adequate response to assessment of symptoms
Hemodynamic instability/medical condition requiring further acute life-saving medical intervention
History of psychiatric disorder that includes suicide attempts within the last 6 months, unmanaged depression or anxiety, hospitalization for psychiatric treatment within the last 6 months
Known brain mass, intracranial hemorrhage, skull fracture
Scalp abnormalities including laceration or bleeding
Presence of ventriculoperitoneal (VP) shunt
Known hematological malignancies, including, but not limited to: multiple myeloma, leukemia, and lymphoma
Known history of Reynaud's Disease compromised liver function, cold agglutination, cold sensitivity, cryoglobulinemia, cryofibrinogenemia, and/or a history of severe migraines
Known or disclosed pregnancy or breast-feeding
Sustains another head or neck injury at the time of concussive injury which requires medical treatment
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| John Zak, MD, MBA | Contact | 216-789-7676 | jzak@tectraum.com | |
| Rebecca Zickert | Contact | rebecca.zickert@brightresearch.com |
| Name | Affiliation | Role |
|---|---|---|
| Brian Reilly, MD | Children's Hospital Medical Center of Akron | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Michigan | Recruiting | Ann Arbor | Michigan | 48109 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D001924 | Brain Concussion |
| ID | Term |
|---|---|
| D000070642 | Brain Injuries, Traumatic |
| D001930 | Brain Injuries |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Sham Cooling Garment Device | Device | The sham cooling garment device will be placed with impaired cooling function (only to the head), with sham treatment temperature being set to 19°C (instead of the therapeutic 6°C specification). There will be no thermal nylon barrier that will be used and flow to the neck bladder will be closed. |
|
| Akron Children's Hospital | Recruiting | Akron | Ohio | 44308 | United States |
|
| Cleveland Clinic Foundation | Not yet recruiting | Cleveland | Ohio | 44125 | United States |
|
| D009422 | Nervous System Diseases |
| D006259 | Craniocerebral Trauma |
| D020196 | Trauma, Nervous System |
| D016489 | Head Injuries, Closed |
| D014947 | Wounds and Injuries |
| D014949 | Wounds, Nonpenetrating |